Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9926602
Recurrent gene fusions in prostate cancer
granted -
US 9920109
Serpin fusion polypeptides and methods of purification thereof
granted -
US 9914927
RNAi inhibition of alpha-ENaC expression
granted -
US 9914765
WAP domain fusion polypeptides and methods of use thereof
granted -
US 9909124
Compounds and methods for modulating apolipoprotein C-III expression for improving a diabetic profile
granted -
US 9902955
Method and medicament for inhibiting the expression of a given gene
granted -
US 9899614
Phosphorescent tetradentate metal complexes having modified emission spectra
granted -
US 9889160
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9889161
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 9884072
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 9885051
Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
granted -
US 9885045
Methods and compositions for modulating apolipoprotein (a) expression
granted -
US 9885047
Modulation of TMPRSS6 expression
granted -
US 9877952
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
granted -
US 9873875
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 9868943
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
granted -
US 9867830
Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
granted -
US 9868950
Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
granted -
US 9862746
Compositions and methods relating to hindering DOT1L recruitment by MLL-fusion proteins
granted -
US 9856310
UTI fusion proteins
granted -
US 9856313
Epitope of RSV fusion protein and antibody recognizing the same
granted -
US 9849100
Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities
granted -
US 9845346
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9844611
Tissue-separating fatty acid adhesion barrier
granted